comprehensive -WSS

comprehensive

author：focus 2025-10-01 23:57:26 - browse：313

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Trump team launching legal defense fund to help pay legal bills

Wikipedia

WSS

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Snowpack in the West is melting rapidly. Where will all that extra water go?

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Europe is fastest

explore

comprehensive

focus

In age of alternative facts, a scholarly course on calling out crap

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

ChatGPT in medicine: STAT answers readers' burning questions

Many immigrants are left out of maternal health programs

BioMarin wins approval for gene therapy to treat hemophilia A

US intelligence assessment says Iran not currently developing nuclear weapons

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to know about a major upcoming Wegovy heart health study

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to know about a major upcoming Wegovy heart health study

entertainment

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Drinking water from half of US faucets contains PFAS: Study

Trump seeks lengthy delay of classified docs trial, citing upcoming election

knowledge

hotspot

Wikipedia

knowledge